Recombinant Virus Like Particles as Drug Delivery System

Abstract

The drug delivery system described here is based on a virus like particle consisting of the recombinant expressed major capsid protein of Polyomavirus, VP1. Polyoma, a murine virus belonging to the Papovaviridae, forms a non-enveloped icosahedral capsid. These capsids are organized as a double shell composed of three different proteins: VP1,VP2 and VP3. The outer shell of the vision is composed of 360 VP1 molecules arranged as 72 pentamers. These capsids have a diameter of about 50 nm. The VP1 protein acts as a major ligand for certain membrane receptors during virus infection. Furthermore, the N-terminus of the VP1 protein contains a DNA-binding domain and a nuclear localization sequence. The recombinant production of the VP1 protein offers a save way to obtain a highly purified, non pathogenic pharmaceutical excipient. Combining these aspects, VP1 proteins provide a targeting as well as a drug binding site when used as a save drug carrier for gene therapy. Current applications are also including oligonucleotides as well as small molecules as well as vaccines.

Pegylation of Nanoliposomal Paclitaxel Enhances its Efficacy in Breast Cancer

“…Drug delivery is one of the main challenges of pharmaceutical biotechnology [15]. It has been shown that nano carriers manage to deliver drugs to targeted cells.…”

Design of Peptide Nanoparticles Using Simple Protein Oligomerization Domains

“…Nature itself provides a rich source of self-assembled nanoscale structures such as viruses, ribosomes and many other highly complex, supramolecular machineries. By combining molecular biology and recombinant protein expression, several self-assembled nanoscale structures derived from nature's repertoire have been prepared for nanobiotechnological applications, including virus-like particles (VLPs) [12,13], ferritin protein cages [14][15][16], heat shock protein cages [17][18][19] and other selfassembled protein cages, such as enzyme complexes [20], chaperones [21], and carboxysomes [22]. According to Lee and Wang [23], the following characteristics make bionanoparticles more attractive compared to synthetic nanoparticles: they have well organized architectures with a broad selection of sizes at the nanometer scale; they are monodisperse with uniform sizes and shapes; their three-dimensional structures can be resolved at atomic or near-atomic resolution; and they can be economically produced at a large scale in gram or even kilogram quantities.…”

Cytotoxicity of Liposomal Paclitaxel in Breast Cancer Cell Line MCF-7

“…Drug delivery is one of the main challenges facing biotech [11]. It has been proven that nanocarriers have the ability to deliver drugs to the targeted cells.…”